WebSep 17, 2007 · Doxorubicin (Adriamycin), a topoisomerase II (Top2)-targeting drug, is one of the most effective anticancer drugs used in the clinic. However, doxorubicin-based … WebWe have analyzed 1 kb of cloned human c-fos sequence (-711 to +287) for calf thymus DNA topoisomerase II cleavage sites in vitro. Using the anti-tumor drug VP16 (demethylepipodophyllotoxin-beta-D-glucoside) with purified topoisomerase II, we identify twelve sites. Five sites are clustered around pos …
Discovery of Novel Topoisomerase II Inhibitors by Medicinal …
WebConclusion: High expression of Topo-IIa in peripheral blood is a favorable indicator of persistent remission, good therapeutic response and DFS. High dCMPD and low CDA expression in bone marrow is associated with poor therapeutic outcome. Keywords: topoisomerase IIα, hENT1, dCMPD, CDA, dCK, survival, AML, antimetabolites, … WebA nice clip i found on the mechanisms of action of topoisomerase 1 and 2 kelly j thomas bremerton wa
Difference Between Topoisomerase I and II
WebJul 31, 2024 · Additionally, topoisomerase-II is dimeric or tetrameric because it has to work on breaking and ligating both strands of DNA. Energy (in the form of ATP) is required for … WebJan 29, 2013 · Topoisomerase II DNA-gyrase during takes energy from ATP hydrolysis to introduce tight supercoils into the DNA helix with a view to condense the chromosome (chromosome condensation) Citation 16. 2.1. Eukaryotic topoisomerase. Eukaryotic topoisomerase are of two types: type I and type II Citation 17 . WebIdarubicin HCl (4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl,Idamycin, Zavedos) is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL in a cell-free assay. Idarubicin induces mTOR-dependent cytotoxic autophagy. kelly j thomas